An official NHS document proves that NHS staff were told respiratory depressing drugs “should not be withheld due to inappropriate concerns” about using them to treat Covid-19; a respiratory disease.
Midazolam can cause serious or life-threatening breathing problems such as shallow, slowed, or temporarily stopped breathing that may lead to permanent brain injury or death, and UK regulators state that you should only receive midazolam in a hospital or doctor’s office that has the equipment that is needed to monitor your heart and lungs and to provide life-saving medical treatment quickly if your breathing slows or stops.
The drug, which is criminally used in palliative care in the United Kingdom despite not being on the WHO’s list of essential palliative care medicines, should also be used with extreme caution in elderly patients.
But despite this, Matt Hancock and the Department of Health ordered two years worth of Midazolam in March 2020 in response to the introduction of the first lockdown. A two year supply that was depleted by October of the same year.
The reason being that the elderly and vulnerable were denied treatment by the NHS; a policy that was part of a pandemic response four years in the planning, and instead put on end of life care which involved withdrawing their medication, depriving them of food and water, and pumping them full of midazolam and morphine until they died of starvation and dehydration.
Evidence suggests that the drug midazolam was used to prematurely end the lives of thousands upon thousands of people in the United Kingdom who you were told had died of Covid-19, and this can be clearly seen from the data on out of hospital prescribing for midazolam coinciding with the waves of all cause deaths and Covid-19 deaths in the UK, as well as the Amnesty and CQC reports which found the blanket use of Do Not Resuscitate orders being used in care homes without informing the residents or their families.